Edition:
India

Granules India Ltd (GRAN.NS)

GRAN.NS on National Stock Exchange of India

135.60INR
3:59pm IST
Change (% chg)

Rs-0.25 (-0.18%)
Prev Close
Rs135.85
Open
Rs135.70
Day's High
Rs137.45
Day's Low
Rs133.75
Volume
1,191,952
Avg. Vol
2,462,406
52-wk High
Rs157.25
52-wk Low
Rs101.25

Latest Key Developments (Source: Significant Developments)

Granules India's Virginia Unit Completes U.S. FDA Audit With 1 Observation
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Granules India Ltd ::SAYS GRANULES PHARMACEUTICALS COMPLETES U.S. FDA INSPECTION WITH 1 OBSERVATION.  Full Article

Granules India Sept-qtr consol profit falls
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Granules India Ltd :Sept quarter consol net profit 403.4 million rupees versus profit 408.2 million rupees year ago.Sept quarter consol revenue from operations 3.93 billion rupees versus 3.64 billion rupees year ago.Declared dividend of 0.25 rupees per share.  Full Article

Granules India gets US FDA nod for Ibuprofen 200 mg tablets
Thursday, 13 Oct 2016 

Granules India Ltd :Granules India says Granules India Limited, received US FDA approval for Ibuprofen 200 mg tablets.  Full Article

Granules India unit to buy 12.5 pct stake in USpharma
Thursday, 14 Jul 2016 

Granules India Ltd : Unit in agreeement with USpharma to acquire 12.5% stake; co will get right of first refusal to market select products .  Full Article

Granules India's Jeedimetla plant gets EIR from US FDA
Monday, 30 May 2016 

Granules India Ltd : Granules India's Jeedimetla plant received Establishment Inspection Report from the US FDA .  Full Article

BRIEF-Granules India's Virginia Unit Completes U.S. FDA Audit With 1 Observation

* SAYS GRANULES PHARMACEUTICALS COMPLETES U.S. FDA INSPECTION WITH 1 OBSERVATION Source text: http://bit.ly/2AK3Fdu Further company coverage: